Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 9/20 | 0.59 |
| ▸ | PPARA | Q07869 | 9/20 | 0.59 |
| ▸ | PPARD | Q03181 | 8/20 | 0.59 |
| ▸ | CYSLTR2 | Q9NS75 | 1/20 | 0.40 |
| ▸ | CYSLTR1 | Q9Y271 | 1/20 | 0.40 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.36 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6936047 | 0.91 | PPARG (0.62) | PPARGPPARAPPARDCYSLTR2CYSLTR1 | |
| SCHEMBL6937885 | 0.90 | PPARG (0.73) | PPARGPPARAPPARDCYSLTR2CYSLTR1 | |
| SCHEMBL6938923 | 0.87 | PPARG (0.57) | PPARGPPARAPPARDCYSLTR2CYSLTR1 | |
| SCHEMBL6938338 | 0.85 | PPARA (0.81) | PPARGPPARAPPARDCYSLTR2CYSLTR1 | |
| SCHEMBL6936685 | 0.84 | PPARG (0.64) | PPARGPPARAPPARDCYSLTR2CYSLTR1 | |
| SCHEMBL6938586 | 0.82 | PPARG (0.62) | PPARGPPARAPPARDCYSLTR2CYSLTR1 | |
| SCHEMBL6937851 | 0.82 | PPARA (0.68) | PPARGPPARAPPARDNR1H2NR1H3 | |
| SCHEMBL6936461 | 0.82 | PPARG (0.59) | PPARGPPARAPPARDCYSLTR2CYSLTR1 | |
| SCHEMBL6938970 | 0.81 | PPARG (0.75) | PPARGPPARAPPARDCYSLTR2CYSLTR1 | |
| SCHEMBL6938580 | 0.80 | PPARG (0.57) | PPARGPPARAPPARDCYSLTR2CYSLTR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0888278-B1 | ANTIDIABETIC AGENTS | MERCK & CO INC (US) | 2003-07-23 | — | — | EP | claimed |